Jul 14, 2016 - Thinly traded micro cap Revance Therapeutics (RVNC) slumps 6% after hours on higher-than-average volume in apparent response to its announcement that it co
Jul 14, 2016 - Allergan's sale of its generic business to Teva is proceeding.Closing the Teva transaction should be a major catalyst for Allergan shares.Capital allocation plan balances M&A flexibility, debt pay dow
Jul 14, 2016 - Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.
Jul 14, 2016 - Teva Pharmaceutical (TEVA) will raise between $20B-$25B next week to finance its acquisition of Allergan's (AGN) generics business, Globes reports. The bon
Jul 13, 2016 - Ruane Cunniff Comments on Allergan, Stocks: AGN, Ruane Cunniff, release date:Jul 13, 2016
Jul 13, 2016 - Sequoia Fund Addresses Valeant, New Buys, Board Changes in 2nd Quarter Letter, Stocks: VRX,IDXX,AGN,CAB,KMX,CMG,SCHW,, Ruane Cunniff, release date:Jul 13, 2016
Jul 13, 2016 - On Wednesday, shares of Allergan (AGN) and Teva Pharmaceuticals (TEVA) are both on the rise, up around 2% and 3%, respectively, in morning trading after Teva CEO Erez Vigodman said it expects its $40.5 billion acquisition of Allergan's generics business to close any day.
Jul 13, 2016 - Those on the acquisition trail last year benefited from a slight dip in average deal values, an EP Vantage analysis shows, as rocky equity markets knocked valuations from their 2014 peak. Data collate
Jul 13, 2016 - Teva's (TEVA) corporate presentation this morning has perked up investors. Shares are up 3% premarket on robust volume. CEO Erez Vigodman said that there a
Jul 13, 2016 - Ahead of its acquisition of Allergan's Generics business, Teva Pharmaceutical (TEVA) raised its second-quarter 2016 guidance for earnings and revenues.